Inhibition of CDK1 can induce apoptosis in several types of malignancy (Ongkeko et al., 1995; Otto & Sicinski, 2017) and could prove effective against cancer stem cells, particularly in gliomas and pancreatic cancers (Sánchez‐Martínez et al., 2019). Here, CDK1 is linked to cancer.